3 reports

  • CHAPTER IV PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • CHAPTER III PROSTATE CANAER TRAETMENT DRUGS INDUSTRY ASSESSMENTS

Prostate cancer is the third most common cause of death from cancer in men of all ages.

  • Cancer
  • Hormone
  • Pharmaceutical
  • Prostate Cancer
  • Hangzhou Sinopep Pharmaceutical Co., Ltd
  • CHAPTER IV PROSTATE CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Prostate Cancer Treatment Drugs Sales Volume

Prostate cancer is the third most common cause of death from cancer in men of all ages.

  • Cancer
  • Hormone
  • Prostate Cancer
  • AstraZeneca Pharmaceutical Co., Ltd
  • Hangzhou Sinopep Pharmaceutical Co., Ltd
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.